IL43568A - Cell respiration stimulant compositions containing blood extract and the cardiotonic heptaminol and their productio - Google Patents

Cell respiration stimulant compositions containing blood extract and the cardiotonic heptaminol and their productio

Info

Publication number
IL43568A
IL43568A IL43568A IL4356873A IL43568A IL 43568 A IL43568 A IL 43568A IL 43568 A IL43568 A IL 43568A IL 4356873 A IL4356873 A IL 4356873A IL 43568 A IL43568 A IL 43568A
Authority
IL
Israel
Prior art keywords
blood
extract
blood extract
salt
dry
Prior art date
Application number
IL43568A
Other versions
IL43568A0 (en
Original Assignee
Solco Basel Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solco Basel Ag filed Critical Solco Basel Ag
Publication of IL43568A0 publication Critical patent/IL43568A0/en
Publication of IL43568A publication Critical patent/IL43568A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Claims (1)

CLAIMS A composition having stimulant effect on cell respiration containing blood extract obtained from blood whic has been carefully freed from diluted and subjected to a dialysis against water or dilute ethanol and then and or a physiologically tolerated acid addition salt A composition according to Claim 1 wherein blood extract having a content of 40 to 45 mg dry substance per ml of extract is A composition according to Claim dosed each dose containing 1 to 5 ml of the blood extract having a content of 40 to 45 mg dry substance pe ml of extract or the equivalent amount of dry o of and 15 to 100 mg of a salt of A composition according to Claim wherein each dose contains 2 ml of the blood extract or the dry thereof and 20 to 80 mg of the heptamlnol A process for the production of a compositio claimed in Claim 1 wherein blood extrac obtained from calf blood which been carefully freed from by ventional then strongly diluted and subjected to a dialysis against water or dilute ethanoli and finally evaporated to a concentration of 40 to 45 mg of dry substance per ml of solution or to a dry lyophilisate or is mixed with or a physiologically accep acid salt thereof in a proportion of to 11 referred to the dry and worked up into injection lyophisates and syrups after adsorption of the active ingredients of the blood extract o substances or into or 14 a A process according to Claim wherein preparations are produced in dosage which per dose 1 to nil of blood extract with a dry content of and 15 to 100 of in the form of its hydrochloride or A process according to Claim 6 wherein dosage having of blood extract 20 to 80 of the heptaniinol salt are A process for the of injectable forms of the composition according to Claims or 7 wherein the salt of is added to the biologically active blood extract in the predetermined and the solution is lyophilised after adjusting the desired concentration by the addition of bidistilled filled into ampoules under sterile A process for the production of solid forms of the composition according to Claims or 7 wherein salt is mixed in the proportion with the biologically active blood extract Ί and the resultant solution is lyophilised or adsorbed solid carriers and or with a lyophilisate or adsorbate of the biologically active blood and the mixture according to or is filled into capsules or mixed with a tablet base material consisting of starch and a swelling or blasting granulated and worked into tablets if given a coating soluble in the after mixing it cacao pressed to form process for the production of liquid forms of composition to Claim or oral wherein A geriatric agent containing 1 to 5 to 225 of blood extract as defined in Claim 1 and 15 to 100 mg of a salt of Compositions according to
1. Claim 1 substantially as herein described exemplified Processes substantially as herein described and exemplified for the production of compositions according to Claim Compositions whenever produced by a process according to any one of Claims 5 to 10 and 16 insufficientOCRQuality
IL43568A 1972-11-16 1973-11-05 Cell respiration stimulant compositions containing blood extract and the cardiotonic heptaminol and their productio IL43568A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1673872 1972-11-16

Publications (2)

Publication Number Publication Date
IL43568A0 IL43568A0 (en) 1974-03-14
IL43568A true IL43568A (en) 1976-05-31

Family

ID=4419791

Family Applications (1)

Application Number Title Priority Date Filing Date
IL43568A IL43568A (en) 1972-11-16 1973-11-05 Cell respiration stimulant compositions containing blood extract and the cardiotonic heptaminol and their productio

Country Status (8)

Country Link
BE (1) BE807455A (en)
DE (1) DE2349186C2 (en)
ES (1) ES420106A1 (en)
FR (1) FR2206941B1 (en)
GB (1) GB1391746A (en)
IL (1) IL43568A (en)
NL (1) NL149371B (en)
SE (1) SE419939B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU206367B (en) * 1988-04-30 1992-10-28 Sandoz Ag Process for producing acid addition salts of steroid carboxylic acid-amidated taurine and glycine, as well as pharmaceutical compositions comprising such salts
DE19518156C2 (en) * 1995-05-17 1997-05-07 Alfons Dr Pfister Use of deproteinized hemodialysate
WO2019074886A1 (en) 2017-10-09 2019-04-18 Terumo Bct Biotechnologies, Llc Lyophilization container and method of using same
US11609042B2 (en) 2019-03-14 2023-03-21 Terumo Bct Biotechnologies, Llc Multi-part lyophilization container and method of use
CN116793783A (en) * 2023-05-26 2023-09-22 司法鉴定科学研究院 Capsule type drug-containing biological matrix freeze-drying reagent and preparation method and application thereof

Also Published As

Publication number Publication date
BE807455A (en) 1974-03-15
NL7315493A (en) 1974-05-20
NL149371B (en) 1976-05-17
FR2206941A1 (en) 1974-06-14
SE419939B (en) 1981-09-07
ES420106A1 (en) 1976-03-16
FR2206941B1 (en) 1977-09-02
GB1391746A (en) 1975-04-23
IL43568A0 (en) 1974-03-14
DE2349186A1 (en) 1974-05-22
DE2349186C2 (en) 1982-11-11

Similar Documents

Publication Publication Date Title
CA1040532A (en) Process for producing solid bismuth-containing pharmaceutical compositions
US4717713A (en) Controlled release liquid pharmaceutical
US4775535A (en) Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
WO1993015724A1 (en) Fast soluble tablet
IE53537B1 (en) Solid shaped articles
GB1471564A (en) Direct compression tabletting composition and tablets produced therefrom
US4855143A (en) Method of preparing controlled long-acting pharmaceutical formulations in unit dosage form having uniform and comparable bioavailability characteristics
JPS599539B2 (en) Nitroglycerin aqueous solution and its manufacturing method
US2656298A (en) Therapeutic product
CN102258531B (en) Medicinal composition containing adenosine cyclophosphate and meglumine and preparation method thereof
CN102133225A (en) Compound polyethylene glycol electrolyte pulvis and preparation method thereof
US4091091A (en) Stabilized nitroglycerin tablets
EP0025686A2 (en) Pharmaceutical composition containing paracetamol, treatment pack comprising said composition and method of reducing liver toxicity effect of paracetamol compositions
RU2329786C1 (en) Medical product for parodentium inflammatory disease treatment and related production method
US2954322A (en) Pharmaceuticals
US3326760A (en) Choline salicylate polygalacturonate therapy
JPS60252415A (en) Stable solid drug composition containing choline salicylate
US1526981A (en) Effervescent alkali compound and process of manufacturing and preparing the same
GB1464467A (en) Pharmaceutical composition for the treatment of coronary
DE2105110A1 (en) Novel drug
RU2057462C1 (en) Method of preparing biologically active food addition
KR890001559A (en) Pharmaceutical Compositions Containing Trapidil, Methods For Making And Related Therapeutic Uses
GB1391746A (en) Stimulative composition and process for its production
CN103536541B (en) Clarithromycin freeze-dried injection and preparation method thereof
CN101695493B (en) composition of cefmetazole acid and sodium citrate